Literature DB >> 33924627

Ultra-High Dose Rate Transmission Beam Proton Therapy for Conventionally Fractionated Head and Neck Cancer: Treatment Planning and Dose Rate Distributions.

Patricia van Marlen1, Max Dahele1, Michael Folkerts2, Eric Abel2, Ben J Slotman1, Wilko Verbakel1.   

Abstract

Transmission beam (TB) proton therapy (PT) uses single, high energy beams with Bragg-peak behind the target, sharp penumbras and simplified planning/delivery. TB facilitates ultra-high dose-rates (UHDRs, e.g., ≥40 Gy/s), which is a requirement for the FLASH-effect. We investigated (1) plan quality for conventionally-fractionated head-and-neck cancer treatment using spot-scanning proton TBs, intensity-modulated PT (IMPT) and photon volumetric-modulated arc therapy (VMAT); (2) UHDR-metrics. VMAT, 3-field IMPT and 10-field TB-plans, delivering 70/54.25 Gy in 35 fractions to boost/elective volumes, were compared (n = 10 patients). To increase spot peak dose-rates (SPDRs), TB-plans were split into three subplans, with varying spot monitor units and different gantry currents. Average TB-plan organs-at-risk (OAR) sparing was comparable to IMPT: mean oral cavity/body dose were 4.1/2.5 Gy higher (9.3/2.0 Gy lower than VMAT); most other OAR mean doses differed by <2 Gy. Average percentage of dose delivered at UHDRs was 46%/12% for split/non-split TB-plans and mean dose-averaged dose-rate 46/21 Gy/s. Average total beam-on irradiation time was 1.9/3.8 s for split/non-split plans and overall time including scanning 8.9/7.6 s. Conventionally-fractionated proton TB-plans achieved comparable OAR-sparing to IMPT and better than VMAT, with total beam-on irradiation times <10s. If a FLASH-effect can be demonstrated at conventional dose/fraction, this would further improve plan quality and TB-protons would be a suitable delivery system.

Entities:  

Keywords:  FLASH; head-and-neck cancer; proton transmission beams; treatment planning; ultrahigh dose-rate

Year:  2021        PMID: 33924627     DOI: 10.3390/cancers13081859

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  6 in total

1.  Single-fraction 34 Gy Lung Stereotactic Body Radiation Therapy Using Proton Transmission Beams: FLASH-dose Calculations and the Influence of Different Dose-rate Methods and Dose/Dose-rate Thresholds.

Authors:  Patricia van Marlen; Wilko F A R Verbakel; Ben J Slotman; Max Dahele
Journal:  Adv Radiat Oncol       Date:  2022-04-10

2.  FLASH Radiotherapy Using Single-Energy Proton PBS Transmission Beams for Hypofractionation Liver Cancer: Dose and Dose Rate Quantification.

Authors:  Shouyi Wei; Haibo Lin; J Isabelle Choi; Robert H Press; Stanislav Lazarev; Rafi Kabarriti; Carla Hajj; Shaakir Hasan; Arpit M Chhabra; Charles B Simone; Minglei Kang
Journal:  Front Oncol       Date:  2022-01-13       Impact factor: 6.244

Review 3.  A roadmap to clinical trials for FLASH.

Authors:  Paige A Taylor; Jean M Moran; David A Jaffray; Jeffrey C Buchsbaum
Journal:  Med Phys       Date:  2022-04-25       Impact factor: 4.506

4.  Dose rate and dose robustness for proton transmission FLASH-RT treatment in lung cancer.

Authors:  Shouyi Wei; Haibo Lin; Sheng Huang; Chengyu Shi; Weijun Xiong; Huifang Zhai; Lei Hu; Gang Yu; Robert H Press; Shaakir Hasan; Arpit M Chhabra; J Isabelle Choi; Charles B Simone; Minglei Kang
Journal:  Front Oncol       Date:  2022-08-15       Impact factor: 5.738

5.  Ultra-high dose rate dosimetry: Challenges and opportunities for FLASH radiation therapy.

Authors:  Francesco Romano; Claude Bailat; Patrik Gonçalves Jorge; Michael Lloyd Franz Lerch; Arash Darafsheh
Journal:  Med Phys       Date:  2022-05-07       Impact factor: 4.506

Review 6.  Future Developments in Charged Particle Therapy: Improving Beam Delivery for Efficiency and Efficacy.

Authors:  Jacinta Yap; Andrea De Franco; Suzie Sheehy
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.